Drew Armstrong
banner
drewsnews.bsky.social
Drew Armstrong
@drewsnews.bsky.social
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky

Priors: Bloomberg News + the Covid vaccine tracker. CQ.
I mean:
December 19, 2024 at 1:52 PM
I wrote about covering a shooting a 13 years ago, how the medium of the moment distorts violence in strange ways, and the strange, worrying moment we're in with the killing of an insurance executive.

endpts.com/post-hoc-wha...
December 11, 2024 at 5:36 PM
Lilly released it's head-to-head with Wegovy today and it appears to have a meaningful edge on long-term weight loss (handy chart from Liz Cairns)
December 4, 2024 at 1:48 PM
👀Warp speed mention in surgeon general announcement...
November 23, 2024 at 1:02 AM
Dr Oz for CMS. Okay then!
November 19, 2024 at 9:11 PM
Interesting piece from @scottgottliebmd.bsky.social on the GLP-1 compounding debate. I'm not sure how you put this back in the bottle -- big market, major cost debate. Feels like a one-way street...
November 19, 2024 at 8:08 PM